Back to search

Article

Repurposed COMT Inhibitors Tolcapone and Entacapone Selectively Suppress Aggregation and Seeding of P301 Mutant TAU in Human Neuronal Models

2026-04-22

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background and Purpose</h4> Pathogenic aggregation and propagation of seed-competent TAU assemblies drive tauopathies. MAPT P301 mutations accelerate aggregation and enhance seed competence, yet pharmacological strategies selectively targeting these pathogenic species remain limited. We investigated whether the clinically approved catechol-O-methyltransferase inhibitors tolcapone (TOL) and...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f5e8608d-e84d-5ee9-b3f1-94b27167f5f7
DOI
10.64898/2026.04.20.719548
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Repurposed COMT Inhibitors Tolcapone and Entacapone Selectively Suppress Aggregation and Seeding of P301 Mutant TAU in Human Neuronal ModelsDOI 10.64898/2026.04.20.719548
Select a neighboring publication to make it the new centre.